Journal
Multiple Sclerosis and Related Disorders
Publication Date
2-1-2022
Volume
58
First Page
103480
Document Type
Open Access Publication
DOI
10.1016/j.msard.2021.103480
Rights and Permissions
Ryerson LZ, Naismith RT, Krupp LB, Charvet LE, Liao S, Fisher E, de Moor C, Williams JR, Campbell N. No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS. Mult Scler Relat Disord. 2022 Feb;58:103480. doi: 10.1016/j.msard.2021.103480. © 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
Recommended Citation
Ryerson, Lana Zhovtis; Naismith, Robert T.; Krupp, Lauren B.; Charvet, Leigh E.; Liao, Shirley; Fisher, Elizabeth; de Moor, Carl; Williams, James R.; and Campbell, Nolan, "No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS." Multiple Sclerosis and Related Disorders. 58, 103480 (2022).
https://digitalcommons.wustl.edu/oa_4/1360
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
